HXCX(SZ:300300)2023-04-27 16:00Financial Performance - The company's operating revenue for Q1 2023 was ¥21,901,242.03, a decrease of 34.52% compared to ¥33,446,148.87 in the same period last year[5] - The net loss attributable to shareholders was ¥18,568,258.84, an improvement of 56.20% from a loss of ¥42,394,191.78 in the previous year[5] - Basic and diluted earnings per share improved to -¥0.03, a 50.00% increase from -¥0.06 in the previous year[5] - Net loss for Q1 2023 was ¥18,585,243.84, an improvement from a net loss of ¥42,761,936.19 in Q1 2022[20] - The total comprehensive income for the first quarter was -18,188,658.29 CNY, compared to -42,901,393.76 CNY in the previous period, showing an improvement[21] Cash Flow - The net cash flow from operating activities was ¥27,646,815.07, a significant increase of 1,522.69% compared to a negative cash flow of ¥1,943,282.76 in the same period last year[5] - Cash inflow from operating activities totaled 86,974,291.39 CNY, down 20.9% from 109,977,262.72 CNY in the previous year[24] - Cash outflow from operating activities was 59,327,476.32 CNY, a decrease of 46.9% compared to 111,920,545.48 CNY last year[24] - The company reported a cash balance of ¥11,304,675.71 at the end of Q1 2023, slightly up from ¥11,243,416.45 at the beginning of the year[15] - Cash and cash equivalents at the end of the period were 6,059,208.45 CNY, down from 11,362,581.94 CNY at the end of the previous year[24] - The net cash flow from financing activities was -28,196,579.54 CNY, worsening from -18,276,918.89 CNY in the previous year[24] Assets and Liabilities - Total assets decreased by 3.98% to ¥1,284,264,250.00 from ¥1,337,464,668.97 at the end of the previous year[5] - Total current assets decreased to ¥435,027,718.95 in Q1 2023 from ¥484,296,568.51 in Q1 2022, a decline of 10.2%[17] - Total liabilities decreased to ¥933,724,330.15 in Q1 2023 from ¥968,736,090.82 in Q1 2022, a reduction of 3.6%[17] - The company's total liabilities decreased, reflecting a strategic focus on cost control and operational efficiency[9] Research and Development - The company's R&D expenses were ¥2,003,131.20, a decrease of 48.64% compared to ¥3,900,028.81 in the same period last year[9] - Research and development expenses decreased to ¥2,003,131.20 in Q1 2023 from ¥3,900,028.81 in Q1 2022, reflecting a reduction of 48.7%[20] Shareholder Information - The total number of common shareholders at the end of the reporting period is 26,246[10] - The top 10 shareholders hold a total of 15.89% of shares, with the largest shareholder, Pingtan Innovation Equity, holding 106,689,174 shares[10] Operational Changes - The company did not dispose of any subsidiaries during the reporting period, indicating a stable operational structure[9] - There were significant changes in the board of directors, including resignations and appointments, which may impact future strategies[13] - The company has completed the registration of changes to its legal representative, which may facilitate operational adjustments[13] - The company has received approval for a subsidiary's IPO application, indicating potential market expansion[13] Cost Management - The company reported a significant reduction in sales expenses, which rose to ¥4,469,354.08, a 94.05% increase from ¥2,303,178.43 in the previous year[9] - The company incurred 31,828,544.07 CNY in cash payments for goods and services, down from 48,723,406.59 CNY last year, reflecting cost control measures[24] Other Information - The report was not audited, indicating that the figures are preliminary and subject to change[25] - The company has not disclosed any new product or technology developments in this report[12] - The company's trading financial assets decreased to ¥22,365,500.41 from ¥23,114,873.97, reflecting a decline of approximately 3.2%[15] - The company aims to enhance its market position through strategic investments and cost management initiatives moving forward[20]